SCHEMBL29800962

SCHEMBL29800962

Cc1cccnc1S(=O)(=O)Nc1cccc2c1NCCC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.42
▸ SLC40A1 Q9NP59 8/20 0.41
▸ KMT2A Q03164 5/20 0.38
▸ TDP1 Q9NUW8 3/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ LMNA P02545 5/20 0.37
▸ HTT P42858 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ S1PR4 O95977 2/20 0.37
▸ S1PR1 P21453 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ MITF O75030 1/20 0.37
▸ AGTR1 P30556 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ CKS1B P61024 1/20 0.37
▸ SKP2 Q13309 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ SRC P12931 1/20 0.36
▸ CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29800812 1.00 ALDH1A1 (0.42) ALDH1A1SLC40A1KMT2ATDP1MEN1
SCHEMBL26964361 1.00 ALDH1A1 (0.42) ALDH1A1SLC40A1KMT2ATDP1MEN1
SCHEMBL30553402 0.86 SLC40A1 (0.43) ALDH1A1SLC40A1TDP1LMNAHTT
SCHEMBL26964376 0.86 SLC40A1 (0.43) ALDH1A1SLC40A1TDP1LMNAHTT
SCHEMBL29800922 0.85 EDNRA (0.37) ALDH1A1SLC40A1KMT2ATDP1MEN1
SCHEMBL27214232 0.85 EDNRA (0.37) ALDH1A1SLC40A1KMT2ATDP1MEN1
SCHEMBL26964470 0.78 ALDH1A1 (0.44) ALDH1A1SLC40A1KMT2ATDP1MEN1
SCHEMBL29800857 0.78 ALDH1A1 (0.44) ALDH1A1SLC40A1KMT2ATDP1MEN1
SCHEMBL6985112 0.78 ALDH1A1 (0.64) ALDH1A1SLC40A1KMT2ATDP1MEN1
SCHEMBL30925585 0.77 ALDH1A1 (0.40) ALDH1A1SLC40A1KMT2ATDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291555-A1 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-12-20 — — EP disclosed
WO-2022173727-A1 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-08-18 — — WO disclosed
Send feedback